Skip to content

Clinical trials

Alzheimer Disease trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Bulgaria Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20074
20082
20092
20111
20122
20133
20143
20153
20163
20172
20201
20211
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline9
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Axovant Sciences Ltd.2
Bristol-Myers Squibb2
H. Lundbeck A/S2
Hoffmann-La Roche2
MapLight Therapeutics2
AB Science1
ACADIA Pharmaceuticals Inc.1
AZTherapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease36
Dementia10
Psychomotor Agitation5
Psychotic Disorders5
Mental Disorders4
Nervous System Diseases4
Brain Diseases3
Cognitive Dysfunction3
Hallucinations3
Neurodegenerative Diseases3

Trials

Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.